1.5 USD
-0.08 (-5.06%)
1.56 USD
+0.06 (+4%)
ChartMill assigns a Buy % Consensus number of 76% to BIOX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.16. This target is 177.66% above the current price.
BIOX was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BIOX.
In the previous month the buy percentage consensus was at a similar level.
BIOX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-14 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2025-09-10 | Lake Street | Maintains | Buy -> Buy |
| 2025-09-10 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-07-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-04-22 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-02-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-07 | Lake Street | Maintains | Buy -> Buy |
| 2025-02-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-01-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-21 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-11 | Roth MKM | Maintains | Buy -> Buy |
| 2024-09-11 | Lake Street | Maintains | Buy -> Buy |
| 2024-09-11 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-09-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-02 | Roth MKM | Reiterate | Buy |
| 2024-02-09 | Roth MKM | Maintains | Buy -> Buy |
| 2023-11-01 | Roth MKM | Maintains | Buy -> Buy |
| 2023-09-12 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-09-12 | Lake Street | Maintains | Buy -> Buy |
| 2023-08-16 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-04-06 | Oppenheimer | Initiate | Outperform |
| 2022-09-30 | Canaccord Genuity | Initiate | Buy |
| 2021-10-08 | Roth Capital | Initiate | Buy |
| 2021-03-15 | Lake Street | Initiate | Buy |
BIOCERES CROP SOLUTIONS CORP / BIOX FAQ
What do analysts expect the price target to be for BIOCERES CROP SOLUTIONS CORP (BIOX)?
10 analysts have analysed BIOX and the average price target is 4.16 USD. This implies a price increase of 177.66% is expected in the next year compared to the current price of 1.5.
What is the consensus rating for BIOX stock?
The consensus rating for BIOCERES CROP SOLUTIONS CORP (BIOX) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for BIOX stock?
The number of analysts covering BIOCERES CROP SOLUTIONS CORP (BIOX) is 10.